Greenstone recalls

Greenstone has 7 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 4 Feb 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls7since 2013

Last 12 months1reported

Class I114% of total

Ongoing1latest 4 Feb 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 1 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 14%Class II 5 71%Class III 1 14%

Why greenstone is recalled

Product types

By year

2026114%
2014457%
2013229%

Ongoing greenstone recalls

1 active

Reported	Class	Recall	Company	Reason	Where
4 Feb 2026Drug	CLASS II	methylprednisolone tablets, USP Dosepak, 4 mg recalled by GreenstoneMethylprednisolone	Greenstone	Other	Nationwide

All greenstone recalls, newest first

7 total

Reported	Class	Recall	Company	Reason	Where
4 Feb 2026Drug	CLASS II	methylprednisolone tablets, USP Dosepak, 4 mg recalled by GreenstoneMethylprednisolone	Greenstone	Other	Nationwide
18 Jun 2014Drug	CLASS I	Venlafaxine HCl Extended-Release Capsules, 150 mg Unit of Use recalled	Greenstone	Packaging Defects	Nationwide
12 Feb 2014Drug	CLASS III	Glipizide XL (glipizide) extended release tablets, 5 mg recalled	Greenstone	Potency & Assay	Nationwide
29 Jan 2014Drug	CLASS II	sertraline HCl tablets, 25 mg recalled by Greenstone	Greenstone	Other	Nationwide
22 Jan 2014Drug	CLASS II	Nifedipine, extended-release tablets, 90mg recalled by Greenstone	Greenstone	Packaging Defects	Nationwide
27 Nov 2013Drug	CLASS II	Spironolactone tablets, USP 50 mg recalled by Greenstone	Greenstone	Potency & Assay	Nationwide
27 Nov 2013Drug	CLASS II	Spironolactone tablets, USP 25 mg recalled by Greenstone	Greenstone	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.